If the candidates were better, then <90% would end their journeys at the clinical trials. Though that's not to say that they've provided any real evidence that their candidates actually are better yet
replyMany times issues with clinical trials is not a technical one, it's a human one, practitioners unwilling to test, patients that stop showing up, red tape, committees, denial of consent, etc. I do not see how AI as it stands currently can solve those issues.
replySo getting drug candidates with high success rate actually is the hard part.
reply